# Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/etrolizumab-as-induction-and-maintenance-therapy-in-patients-with-moderately-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | William J. Sandborn,Julián Panés,Silvio Danese,Zaineb Sharafali,Azra Hassanali,Rhian Jacob-Moffatt,Christopher Eden,Marco Daperno,John F. Valentine,David Laharie,Carolina Baía,Raja Atreya,Remo Panaccione,Grażyna Rydzewska,Humberto Aguilar,Séverine Vermeire |
| Citations | 73 |
| DOI | 10.1016/s2468-1253(22)00303-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4304692114 |
| PMID | 36240801 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Grażyna Rydzewska](https://scholariq.org/researchers/grazyna-rydzewska/)

## Paper journal

- [˜The œLancet. Gastroenterology & hepatology](https://scholariq.org/journals/the-lancet-gastroenterology-and-hepatology/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.